Skip to content

Effect of fluid bolus and vasopressor administration on dynamic arterial elastance in liver transplant recipient.

Variation in dynamic arterial elastance induced by fluid bolus and vasopressor administration in liver transplant recipient - A prospective observational cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053484
Enrollment
54
Registered
2023-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

None listed

Sponsors

Mahatma Gandhi Medical Colllege and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Chronic liver disease patient posted for liver transplant Age (18-65)

Exclusion criteria

Exclusion criteria: Acute liver failure patients Paediatric patient posted for liver transplant ( age 0-18) Patients posted for combined liver and kidney transplant Patients with recent history of cerebral bleed ( Recurrent cardiac arrhythmia Reduced systolic ventricular function (LVEF Chronic lung disease Intraoperative use of vasopressor prior to start of study Extreme body weight patients (BMI > 40 or <15 kg/m2)

Design outcomes

Primary

MeasureTime frame
Study Eadyn alterations induced by intravenous volume expansion and vasopressor infusion in liver transplant recipients.Timepoint: Hemodynamic parameters will be recorded 1) Baseline, 2) Before volume expansion/vasopressor, 3) 5 minutes after volume expansion/vasopressor,

Secondary

MeasureTime frame
To access the potential of baseline Eadyn to anticipate an increase in arterial pressure following volume expansion intra-operatively. Timepoint: Hemodynamic parameters will be recorded 1) Baseline, 2) Before volume expansion/vasopressor, 3) 5 minutes after volume expansion/vasopressor,;To analyse disparity in hemodynamic variables induced by intravenous volume expansion and vasopressor infusion in liver transplant recipients. Timepoint: Hemodynamic parameters will be recorded 1) Baseline, 2) Before volume expansion/vasopressor, 3) 5 minutes after volume expansion/vasopressor,;To confirm the usefulness of Eadyn as a predictor of the arterial pressure response to intravenous fluid administration and vasopressor infusion by simultaneously measuring SVV and PPV.Timepoint: Hemodynamic parameters will be recorded 1) Baseline, 2) Before volume expansion/vasopressor, 3) 5 minutes after volume expansion/vasopressor,;To elucidate the association between baseline Eadyn and rise in arterial pressure induced by intravenous volume expansion and vasopressor infusion. Timepoint: Hemodynamic parameters will be recorded 1) Baseline, 2) Before volume expansion/vasopressor, 3) 5 minutes after volume expansion/vasopressor,

Countries

India

Contacts

Public ContactAnshul Vishnoi

Mahatma Gandhi University of Medical Science & Technology

ganesh.nimje8@gmail.com9503332784

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026